EGFR and villous adenoma: In most samples (52.95%), EGFR amplification was observed, which may lead to abnormal activation of the MAPK/PI3K pathways, contributing to increased cell proliferation and oncogenesis; this phenomenon reached 87.5% in villous adenoma patients.